High-order combination effects and biological robustness

被引:77
作者
Lehar, Joseph [1 ,2 ]
Krueger, Andrew [2 ]
Zimmermann, Grant [1 ]
Borisy, Alexis [1 ]
机构
[1] CombinatoRx Inc, Cambridge, MA 02142 USA
[2] Boston Univ, Boston, MA 02215 USA
关键词
chemical genetics; combinations; epistasis; robustness; synergy;
D O I
10.1038/msb.2008.51
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biological systems are robust, in that they can maintain stable phenotypes under varying conditions or attacks. Biological systems are also complex, being organized into many functional modules that communicate through interlocking pathways and feedback mechanisms. In these systems, robustness and complexity are linked because both qualities arise from the same underlying mechanisms. When perturbed by multiple attacks, such complex systems become fragile in both theoretical and experimental studies, and this fragility depends on the number of agents applied. We explore how this relationship can be used to study the functional robustness of a biological system using systematic high-order combination experiments. This presents a promising approach toward many biomedical and bioengineering challenges. For example, high-order experiments could determine the point of fragility for pathogenic bacteria and might help identify optimal treatments against multi-drug resistance. Such studies would also reinforce the growing appreciation that biological systems are best manipulated not by targeting a single protein, but by modulating the set of many nodes that can selectively control a system's functional state.
引用
收藏
页数:6
相关论文
共 51 条
[1]   Multiple weak hits confuse complex systems: A transcriptional regulatory network as an example [J].
Agoston, V ;
Csermely, P ;
Pongor, S .
PHYSICAL REVIEW E, 2005, 71 (05)
[2]   Error and attack tolerance of complex networks [J].
Albert, R ;
Jeong, H ;
Barabási, AL .
NATURE, 2000, 406 (6794) :378-382
[3]   Computational analysis of the synergy among multiple interacting genes [J].
Anastassiou, Dimitris .
MOLECULAR SYSTEMS BIOLOGY, 2007, 3 (1)
[4]  
Araujo R.P., 2004, DRUG DISCOV TODAY, V1, P425, DOI [DOI 10.1016/J.DDSTR.2004.11.004, DOI 10.1016/j.ddstr.2004.11.004, 10.1016/j.ddstr.2004.11.004]
[5]   Proteins, drug targets and the mechanisms they control: the simple truth about complex networks [J].
Araujo, Robyn P. ;
Liotta, Lance A. ;
Petricoin, Emanuel F. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) :871-880
[6]   Emergence of scaling in random networks [J].
Barabási, AL ;
Albert, R .
SCIENCE, 1999, 286 (5439) :509-512
[7]   Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis [J].
Bhusal, Y ;
Shiohira, CM ;
Yamane, N .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (04) :292-297
[8]   Virus dynamics and drug therapy [J].
Bonhoeffer, S ;
May, RM ;
Shaw, GM ;
Nowak, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6971-6976
[9]   Systematic discovery of multicomponent therapeutics [J].
Borisy, AA ;
Elliott, PJ ;
Hurst, NW ;
Lee, MS ;
Lehár, J ;
Price, ER ;
Serbedzija, G ;
Zimmermann, GR ;
Foley, MA ;
Stockwell, BR ;
Keith, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7977-7982
[10]   Genome-wide RNAi analysis of growth and viability in Drosophila cells [J].
Boutros, M ;
Kiger, AA ;
Armknecht, S ;
Kerr, K ;
Hild, M ;
Koch, B ;
Haas, SA ;
Paro, R ;
Perrimon, N .
SCIENCE, 2004, 303 (5659) :832-835